Follow the 박셀바이오 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 박셀바이오 has logged 2 insider filings. Market capitalisation: €94.3bn. The latest transaction was disclosed on 27 March 2026 (Purchase). Among the most active insiders: 이제중. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
박셀바이오 是一家在XKRX市场上市的医疗保健和制药公司。它专注于创新疗法和生物解决方案的开发。